Skip to content
AnalystLens
Back to NBIXIncome Statement

Neurocrine Biosciences Gross Profit 2015-2026 | NBIX

Annual FY2015–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$2.81B

+21.0%YoY vs FY2024Source: 10-KFY2025

From $19.8M in FY2015 to $2.81B in FY2025: 142.1× in 10 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$801M+42.1%Not reportedNot reportedNot reported
FY25$563M+10.9%$676M+16.4%$781M+27.2%$788M+27.4%
FY24$508M+23.3%$581M+31.7%$614M+25.9%$618M+22.0%
FY23$412M+34.6%$441M+18.2%$488M+27.7%$507M+25.3%
FY22$306M+30.9%$373M+30.7%$382M+30.8%$404M+31.3%
Share21%25%27%27%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+22.1%

FY2020
$1.04B
FY2025
$2.81B

5 years selected · on the chart

Gross Profit History

Year-over-year comparison from 10-K annual reports

  1. $2.81B
YoY changeLargest recent move+178.3%in FY18Latest +21.0%

2 older moves run past ±150% (largest +969.1%); point at, tap or drag across the bars to read one.

Gross Profit, period by period

PeriodValueChangeSource
FY2025$2.81B+21.0%10-K
FY2024$2.32B+25.7%10-K
FY2023$1.85B+26.1%10-K
FY2022$1.47B+30.9%10-K
FY2021$1.12B+8.1%10-K
FY2020$1.04B+132.1%10-K
FY2018$446.3M+178.3%10-K
FY2017$160.4M+969.1%10-K
FY2016$15.0M−24.1%10-K
FY2015$19.8M—10-K

What is gross profit?

Gross profit can be defined as revenue minus the cost of goods sold, representing the profit a company makes before deducting operating expenses.

What is Neurocrine Biosciences's current gross profit?

Neurocrine Biosciences (NBIX) annual gross profit for 2025 was $2.81B, a 20.98% increase from 2024. Neurocrine Biosciences gross profit for the quarter ending March 31, 2026 was $800.7M.

What was Neurocrine Biosciences's gross profit in 2024?

Neurocrine Biosciences annual gross profit for 2024 was $2.32B, a 25.65% increase from 2023.

What was Neurocrine Biosciences's gross profit in 2023?

Neurocrine Biosciences annual gross profit for 2023 was $1.85B, a 26.06% increase from 2022.

What is Neurocrine Biosciences's 5-year gross profit CAGR?

Neurocrine Biosciences gross profit grew at a compound annual growth rate (CAGR) of 22.08% from FY2020 to FY2025, going from $1.04B to $2.81B over 5 years.

Company
Neurocrine Biosciences
Ticker
NBIX
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)